OncoImmune

About:

OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.

Top Investors: Kaitai Capital, 3E Bioventures, GF Xinde Investment Management, Huimei Capital, GBA Fund

Description:

OncoImmune is a clinical-stage biopharmaceutical company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. It has completed a Phase II clinical trial of CD24Fc for the prophylactic treatment of acute Graft versus Host Disease for leukemia patients undergoing hematopoietic stem cell transplantation and is poised to launch a pivotal trial for the indication. Oncolmmune was founded in 2000 and is based in Rockville, Maryland.

Total Funding Amount:

$74M

Estimated Revenue Range:

$10B+

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2000-01-01

Contact Email:

admin(AT)oncoimmune.com

Founders:

Kun-Liang Guan, Ming You, Pan Zheng, Yang Liu

Number of Employees:

10001+

Last Funding Date:

2020-09-09

IPO Status:

Private

Industries: